InvestorsHub Logo
Followers 29
Posts 940
Boards Moderated 0
Alias Born 03/10/2014

Re: None

Tuesday, 05/19/2015 7:52:41 PM

Tuesday, May 19, 2015 7:52:41 PM

Post# of 130502
$AMBS$ Eltoprazine Study???

SO, I wonder just how soon this Phase 2b will be announced...
I wouldn't be surprised if it is not announced at one of the upcoming investor conferences...
Just a thought!

In September 2014, we submitted a request to the FDA for a review and written feedback of our Phase 2b program clinical trial design for Eltoprazine in PD LID. We have received feedback from the FDA on our trial design, and are in the process of preparing a full IND submission for this important therapeutic indication. Following initiation of our Phase 2b program clinical study of Eltoprazine in PD LID, we will submit a request to the FDA regarding further clinical development of Eltoprazine in Adult ADHD. In March 2015, the company received notification of approval from the FDA that IND 124224 was approved and allows the company to commence this clinical trial.




In My Own Personal Opinion Of Course.

In My Own Personal Opinion Of Course!
Long ANAS!